Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Turning Unused PTO Into Cold, Hard Cash
Veetahl Eilat-Raichel, Founder and CEO of Sorbet, shares how employees can harness the value of their time off – and how companies can use PTO to employees’ benefit.
Fed Interest Rate Decision Coming Next Week
Brooke May, Managing Partner at Evans May Wealth, weighs in on how the market is expected to perform through the rest of 2024, plus why she’s still bullish on tech but cautious when it comes to financials.
Load More